• Selective Spectrophotometric Analysis for β-Lactam Antibioti

  2026-06-09

  This study introduces two selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics, including their combinations with penicillin-class agents like dicloxacillin. The approaches enable practical, robust analysis in pharmaceutical research, with direct implications for MSSA-targeted antibiotic studies.

• PNU 74654: Precision Wnt Signaling Pathway Inhibitor Workflo

  2026-06-09

  PNU 74654 empowers researchers to dissect Wnt/β-catenin signaling with high specificity, supporting advanced cancer and stem cell research. This guide translates landmark findings into hands-on protocols, troubleshooting advice, and advanced applications for robust, reproducible results.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Use and Prot

  2026-06-08

  E. coli Uracil-DNA Glycosylase (UDG) is designed for precise removal of uracil from DNA templates, addressing PCR product contamination and supporting DNA repair enzyme research. It is not suitable for RNA substrates, oligonucleotides shorter than six bases, or any diagnostic or clinical use.

• Stattic: STAT3 Inhibitor Workflows for Cancer Cell Assays

  2026-06-08

  Stattic’s selective inhibition of STAT3 dimerization empowers researchers to dissect cancer pathways and radiosensitization mechanisms with precision. Explore protocol optimizations, troubleshooting, and real-world insights from recent breakthroughs in STAT3-driven lymphangiogenesis and apoptosis induction in cancer cells.

• Fluorouracil in Solid Tumor Research: Advanced Protocols & S

  2026-06-07

  Fluorouracil (Adrucil) delivers reproducible inhibition of DNA replication for colon and breast cancer research, with robust workflows for both in vitro and in vivo studies. This guide details advanced protocol enhancements, troubleshooting strategies, and actionable insights to maximize the scientific impact of APExBIO’s validated reagent.

• ORAI2-Driven SOCE Promotes Early Salivary Gland Fibrosis Pos

  2026-06-06

  The reference study delineates ORAI2 as a pivotal driver of early-stage postirradiation fibrosis in salivary glands, mapping a novel ORAI2/JNK/NFAT1/TGF-β1 axis. These findings clarify calcium-mediated mechanisms in radiation-induced tissue damage and highlight new molecular targets for mitigating hyposalivation and fibrosis after radiotherapy.

• Patient-Derived Gastric Cancer Assembloid Models Advance Dru

  2026-06-05

  This study presents a novel patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations. The approach closely mirrors primary tumor complexity and reveals how stromal elements modulate drug responses, offering new precision tools for preclinical and personalized therapy research.

• Parathyroid hormone (1-34) (human): Applied Workflows and In

  2026-06-05

  Parathyroid hormone (1-34) (human) unlocks high-fidelity modeling of bone and kidney function, powering cutting-edge disease research. This guide distills experimental protocols, troubleshooting insights, and actionable workflow enhancements, bridging bench success and translational impact.

• WP1066, JAK2/STAT3 Inhibitor, Cell-Permeable: Reliable Assay

  2026-06-04

  This article addresses common laboratory challenges in cell-based assays and translational cancer research, focusing on evidence-based deployment of WP1066, JAK2/STAT3 inhibitor, cell-permeable (SKU A4140). Drawing on recent literature and validated protocols, we guide biomedical researchers toward reproducible, sensitive results in proliferation, cytotoxicity, and regenerative workflows.

• Transdermal HA-Lipid Nanoparticle Delivery of PTEN mRNA in M

  2026-06-04

  This study presents a hyaluronated lipid nanoparticle (HA-LNP) platform for transdermal delivery of PTEN mRNA, targeting melanoma through CD44-mediated uptake. The approach restores tumor suppressor function, enhances antitumor immunity, and demonstrates significant tumor growth inhibition with improved biocompatibility, offering a promising advance for localized mRNA-based cancer immunotherapy.

• AMPA Receptor Blockade: IEM 1460 as a Translational Tool

  2026-06-03

  This in-depth thought-leadership article explores the mechanistic foundation and strategic relevance of IEM 1460, a selective AMPA receptor blocker, for translational neuroscience research. Integrating recent preclinical findings and workflow recommendations, it positions IEM 1460 as a pivotal asset for researchers studying excitotoxicity, neuroprotection, and synaptic modulation. The article bridges mechanistic insight with practical guidance, highlighting how APExBIO’s IEM 1460 advances beyond standard product pages and supports next-generation neuroprotection strategies.

• ARCA EGFP mRNA: Rethinking Controls in Translational mRNA De

  2026-06-03

  Explore how ARCA EGFP mRNA, with its advanced anti-reverse cap analog and optimized poly(A) tail, is redefining the gold standard for fluorescence-based transfection control. This article connects mechanistic insight with strategic recommendations for translational researchers, drawing on the latest advances in targeted mRNA delivery—such as post-stroke neuroprotection—while clarifying best practices for experimental design and protocol optimization. Distinct from routine product discussions, this piece bridges practical laboratory needs with emerging clinical directions, providing actionable guidance and critical context for next-generation mRNA therapeutics.

• TMEM16F Lipid Scrambling Modulates Ferroptosis and Tumor Imm

  2026-06-02

  Yang et al. reveal that TMEM16F-mediated lipid scrambling suppresses the execution phase of ferroptosis by remodeling plasma membrane phospholipids, thereby preventing catastrophic cell death. Inhibiting this mechanism not only heightens ferroptosis sensitivity but also synergizes with immune checkpoint blockade to drive tumor rejection, opening new avenues for cancer research and therapeutic design.

• G418 Sulfate (Geneticin): Selection & Antiviral Workflow Mas

  2026-06-02

  G418 Sulfate (Geneticin) elevates cell line selection and antiviral research through rigorous, reproducible selection and quantified Dengue virus inhibition. Discover advanced workflows, troubleshooting strategies, and experimental parameters that set APExBIO’s ultra-pure G-418 apart in modern molecular biology.

• Entinostat (MS-275): Strategic Advances in Translational Onc

  2026-06-01

  Explore how Entinostat (MS-275, SNDX-275) is redefining translational cancer research by bridging mechanistic insights in HDAC inhibition with actionable guidance for experimental and clinical teams. This article contextualizes recent in vitro advances, benchmarks APExBIO's Entinostat against the competitive field, and delivers strategic recommendations for oncology researchers.

15592 records 1/1040 page Next 12345 下5页 Last page